Unknown

Dataset Information

0

Targeting Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH): Potential Role of the FGF Signaling Pathway in the Development of the Pulmonary Vascular System.


ABSTRACT: More than 50 years after the first description of Bronchopulmonary dysplasia (BPD) by Northway, this chronic lung disease affecting many preterm infants is still poorly understood. Additonally, approximately 40% of preterm infants suffering from severe BPD also suffer from Bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH), leading to a significant increase in total morbidity and mortality. Until today, there is no curative therapy for both BPD and BPD-PH available. It has become increasingly evident that growth factors are playing a central role in normal and pathologic development of the pulmonary vasculature. Thus, this review aims to summarize the recent evidence in our understanding of BPD-PH from a basic scientific point of view, focusing on the potential role of Fibroblast Growth Factor (FGF)/FGF10 signaling pathway contributing to disease development, progression and resolution.

SUBMITTER: Chao CM 

PROVIDER: S-EPMC7464452 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH): Potential Role of the FGF Signaling Pathway in the Development of the Pulmonary Vascular System.

Chao Cho-Ming CM   Chong Lei L   Chu Xuran X   Shrestha Amit A   Behnke Judith J   Ehrhardt Harald H   Zhang Jinsan J   Chen Chengshui C   Bellusci Saverio S  

Cells 20200811 8


More than 50 years after the first description of Bronchopulmonary dysplasia (BPD) by Northway, this chronic lung disease affecting many preterm infants is still poorly understood. Additonally, approximately 40% of preterm infants suffering from severe BPD also suffer from Bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH), leading to a significant increase in total morbidity and mortality. Until today, there is no curative therapy for both BPD and BPD-PH available. It has bec  ...[more]

Similar Datasets

| S-EPMC8395179 | biostudies-literature
| S-EPMC7979539 | biostudies-literature
| S-EPMC7664991 | biostudies-literature
| S-EPMC6938142 | biostudies-literature
| S-EPMC5874528 | biostudies-literature
| S-EPMC6681505 | biostudies-literature
| S-EPMC3569611 | biostudies-literature
| S-EPMC6226353 | biostudies-literature
| S-EPMC6938152 | biostudies-literature
| S-EPMC3401871 | biostudies-literature